Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHF 1535 versus beclomethasone in adults with mild to moderate persistent asthma
2004-000718-37Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing CHF 1535 combination arm with Becloforte monotherapy comparator arm (2 arms). Primary endpoint: Morning peak expiratory flow at end of treatment. Started Jul 2004; status: completed.
02
Drugs
beclometasone dipropionate + formoterolbeclomethasone dipropionate
03
Conditions
asthma
Beyond the preview
Go deeper on 2004-000718-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000718-37.